Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Optimizing surveillance for the growing population of breast cancer survivors remains a ...
Targeted therapies built around specific genetic driver mutations have become a cornerstone of preci...
The purpose of this study was to develop and validate lesion identification in oncologic nuclear ima...
INTRODUCTION: Lung cancer ranks first globally in cancer-associated mortality, with Lung Adenocarcin...
Allogeneic natural killer (NK) cell therapies have a favorable safety profile. NK cell cytotoxicity ...
INTRODUCTION: The 1,2,3-triazole scaffold is a privileged heterocyclic motif in medicinal chemistry ...
INTRODUCTION/OBJECTIVE: Multidrug Resistance (MDR) remains a major obstacle to effective cancer chem...
BACKGROUND: Convolutional neural networks can classify thyroid nodules on ultrasound, yet published ...
PURPOSE/BACKGROUND: Tumors with microsatellite instability high/mismatch repair-deficient (MSI-H/dMM...
PURPOSE: Diffuse midline glioma (DMG) remains one of the most lethal cancers affecting children, ado...
While chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of hematolog...
BACKGROUND: Hepatocellular carcinoma (HCC) exhibits molecular heterogeneity that challenges histopat...
ETHNOPHARMACOLOGICAL RELEVANCE: Paris polyphylla Smith var. yunnanensis (Franch.) Hand.-Mazz., a tra...
OBJECTIVES: This systematic review aimed to synthesize evidence on artificial intelligence (AI) meth...
BACKGROUND: Schizophrenia spectrum disorders (SSDs) are chronic conditions associated with profound ...
RATIONALE AND OBJECTIVES: To evaluate the performance of nomogram integrating MRI-based deep learnin...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of malig...
OBJECTIVE: Cervical cancer remains a major cause of illness and death among women worldwide, especia...
Chimeric antigen receptor T-cell (CAR-T) therapy is a transformative tumor immunotherapy that redire...
Hepatocellular carcinoma (HCC) patients show heterogeneous responses to immune checkpoint inhibitors...
Ductal carcinoma in situ (DCIS) is a non-invasive precursor of invasive ductal carcinoma (IDC), yet ...